您的位置: 首页 > 农业专利 > 详情页

BIOAVAILABILITY OF ORAL METHYLNALTREXONE INCREASES WITH A PHOSPHATIDYLCHOLINE-BASED FORMULATION
专利权人:
The University of Chicago
发明人:
Chun-Su Yuan,Chong-Zhi Wang,Maojian Gu,Dong-Hai Lin
申请号:
US14398914
公开号:
US20150190523A1
申请日:
2013.03.13
申请国别(地区):
US
年份:
2015
代理人:
摘要:
A pharmaceutical composition comprising a phosphatidylcholine-based opioid receptor antagonist formulation, as well as methods of their use and methods of their preparation are provided herein. Such pharmaceutical composition may be used for treating and preventing opioid-induced side effects in patients, and may be provided to chronic opioid users as well.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充